US Map / Ohio
State OH

Clinical Trials in Ohio

Recruiting clinical trials with at least one study location in Ohio. Data updated daily from ClinicalTrials.gov.

Total Trials
456
Recruiting Now
456
← Back to US Map
Top Conditions in Ohio
Advanced Solid Tumor (8)Acute Myeloid Leukemia (8)Breast Cancer (7)Endometrial Cancer (7)Malignant Solid Neoplasm (6)Cancer (6)Prostate Cancer (6)Ovarian Cancer (5)Sickle Cell Disease (5)Solid Tumor (5)Colorectal Cancer (5)Suicidal Ideation (4)
NCT06447168 N/A
Recruiting
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in P...
Condition
Primary Biliary Cholangitis
Enrollment
424 pts
Location
United States, Austria, Canada
Sponsor
Ipsen
View Trial →
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcapr...
Condition
Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
View Trial →
NCT03471260 Phase 1, Phase 2
Recruiting
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With ...
Condition
Acute Myeloid Leukemia
Enrollment
96 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT05919680 Phase 2
Recruiting
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease...
Condition
Intestinal Failure Associated Liver Disease
Enrollment
36 pts
Location
United States
Sponsor
NorthSea Therapeutics B.V.
View Trial →
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
View Trial →
NCT03761108 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory M...
Condition
Multiple Myeloma
Enrollment
387 pts
Location
United States, Belgium, Germany
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, Germany
Sponsor
Boston Scientific Corporation
View Trial →
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation
View Trial →
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
View Trial →
NCT06810518 N/A
Recruiting
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stoo...
Condition
Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
Enrollment
220 pts
Location
United States
Sponsor
American Laboratory Products C
View Trial →
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04995562 Phase 4
Recruiting
Use of Hyperpolarized 129Xe MR Lung Imaging in Infants
Condition
Lungs; Developmental Disorder
Enrollment
12 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT05784246 Phase 3
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to ...
Condition
Ulcerative Colitis
Enrollment
60 pts
Location
United States, Belgium, Canada
Sponsor
Eli Lilly and Company
View Trial →
NCT06896942 N/A
Recruiting
Autism Doula Program Evaluation
Condition
Health Equity
Enrollment
52 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT06172569 N/A
Recruiting
Spartan Stem, World Cup and World Liner Post Market Clinical Follow-up Study
Condition
Hip Replacement
Enrollment
200 pts
Location
United States
Sponsor
Signature Orthopaedics
View Trial →
NCT03932786 N/A
Recruiting
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Condition
Retinoblastoma
Enrollment
900 pts
Location
United States, Canada
Sponsor
Vanderbilt-Ingram Cancer Cente
View Trial →
NCT07208669 N/A
Recruiting
Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Imp...
Condition
Blood Pressure Control
Enrollment
4 pts
Location
United States
Sponsor
Elizabeth Pfoh
View Trial →
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
View Trial →
NCT06091254 Phase 3
Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Work...
Condition
Follicular Lymphoma (FL)
Enrollment
822 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06456554 N/A
Recruiting
Acellular Dermal Matrix Investigation in Breast Reconstruction
Condition
Breast Reconstruction
Enrollment
467 pts
Location
United States
Sponsor
RTI Surgical
View Trial →
NCT05243966 N/A
Recruiting
Myriad™ Augmented Soft Tissue Reconstruction Registry
Condition
Abdominal Wound Dehiscence
Enrollment
800 pts
Location
United States
Sponsor
Aroa Biosurgery Limited
View Trial →
NCT06029660 N/A
Recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of...
Condition
Aortic Aneurysm, Abdominal
Enrollment
180 pts
Location
United States, France, Netherlands
Sponsor
Shape Memory Medical, Inc.
View Trial →
NCT06501196 Phase 1
Recruiting
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Highe...
Condition
Leukemia
Enrollment
170 pts
Location
United States
Sponsor
BlossomHill Therapeutics
View Trial →
NCT06045754 Phase 4
Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Usteki...
Condition
Crohn's Disease
Enrollment
100 pts
Location
United States, Canada
Sponsor
Takeda
View Trial →
Page 3 of 19 — 456 trials total
← Prev Next →